Partners & News

Featured Updates

  • NaDeNo Presents at GoCo Investor Day

    September 10, 2025

    NaDeNo Presents at GoCo Investor Day

    Organized by GoCo Health Innovation City and AstraZeneca’s BioVentureHub  See Chief Medical Officer Dr. Jens Bjørheim present and take questions from this event in Gothenburg, Sweden Sept 9th, 2025. https://youtu.be/J4Se-7hpshw?si=wV7qGTkthmrA993U

  • NaDeNo joins AstraZeneca BioVentureHub

    April 3, 2025

    NaDeNo joins AstraZeneca BioVentureHub

    We are proud to announce that NaDeNo Nanoscience AS has been selected to join the AstraZeneca BioVentureHub, located at AstraZeneca’s R&D center in Gothenburg, Sweden. The BioVentureHub is an invitation-only ecosystem designed to foster close collaboration between emerging life science companies and AstraZeneca’s scientific and development teams. As the second Norwegian company to join, NaDeNo’s [...]

NaDeNo Collaborates With Leading Organizations

A selection of partners across the healthcare and research ecosystem

Innovation & Testing

Organizations that contribute to preclinical research, early testing, and technology development.

Clinical Development

Renowned clinical institutions driving patient-focused trials to validate efficacy and safety in real-world settings.

Manufacturing & Supply Chain

Partners enabling production, scalability, and raw material sourcing.

Funding & Ecosystems

Organizations providing financial support, innovation clusters, and strategic networks.

Latest Updates

  • NaDeNo welcomes Gudrun Trøite as Head of Operations

    August 28, 2024

    NaDeNo welcomes Gudrun Trøite as Head of Operations

    We are thrilled to welcome Gudrun Trøite to the NaDeNo team as Head of Operations. Gudrun has 20 years’ drug development experience from the Norwegian biotech industry, including Ultimovacs ASA and Photocure, where she has held various leading roles within clinical operations, regulatory and quality assurance. She has successfully led multi-national studies within various indications [...]

  • Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models

    February 27, 2023

    Intraperitoneal administration of cabazitaxel-loaded nanoparticles in peritoneal metastasis models

    Read the full publication here What you’ll learn in this article: PACA drug encapsulation improves treatment response in peritoneal metastases models. Intraperitoneal injection of PACA nanoparticles provides a beneficial drug biodistribution. Drug encapsulation in PACA nanoparticles improves intraperitoneal drug retention. The taxane cabazitaxel is a promising chemotherapy option for peritoneal metastases. Abstract: Colorectal and ovarian [...]

  • NaDeNo referenced in Norwegian Scitech News — Combating severe cancer with a new drug delivery system

    January 31, 2023

    NaDeNo referenced in Norwegian Scitech News — Combating severe cancer with a new drug delivery system

    Reda the full article here Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It [...]

  • NaDeNo Feaured in Norwegian SciTechNews

    January 31, 2023

    NaDeNo Feaured in Norwegian SciTechNews

    What you’ll learn in this article: This article from Norwegian SciTech News will provide deeper understanding of NaDeNo’s innovative nanoparticle-based drug delivery system. Read the full article Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called [...]

  • Combating severe cancer with a new drug delivery system

    February 28, 2021

    Combating severe cancer with a new drug delivery system

    Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It is a spin-off from SINTEF, [...]

  • Combating severe cancer with a new drug delivery system

    February 22, 2021

    Combating severe cancer with a new drug delivery system

    Peritoneal cancer is difficult to treat and has a poor survival prognosis. But a new and effective nanomedicine delivery system is offering some hope. The company is called NaDeNo and is well underway with the development of a new cure for cancers that have spread to the peritoneal cavity. It is a spin-off from SINTEF, [...]